<PAGE>
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 2)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended April 2, 1999 Commission File Number 0-23832
PSS WORLD MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
Florida 59-2280364
(State of Incorporation) (I.R.S. Employer
Identification No.)
4345 Southpoint Boulevard
Jacksonville, Florida 32216
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: (904) 332-3000
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value per share
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes [X] No [_]
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of the Form 10-K or any amendment to this
Form 10-K.
The aggregate market value of common stock, par value $0.0 1 per share (the
"Common Stock") held by nonaffiliates, based upon the closing sales price, was
approximately $843,138,045 as of July 7, 1998. In the determination of this
amount, affiliates include all of the Company's officers, directors and persons
known to the Company to be beneficial owners of more than five percent of the
Company's Common Stock. This amount should not be deemed conclusive for any
other purpose. As of July 7, 1998, a total of 70,209,174 shares of the Company's
Common Stock were outstanding.
<PAGE>
The Signature Page of the Form 10-K of PSS World Medical, Inc. filed with
the Commission on July 16, 1999 (as amended pursuant to the Form 10-K/A filed on
July 22, 1999) is hereby amended as follows to correctly reflect the signatures
of the officers and directors obtained on its Annual Report on Form 10-K for the
fiscal year ended April 2, 1999:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Jacksonville, State of
Florida, on July 16, 1999.
PSS WORLD MEDICAL, INC.
By: /s/ Patrick C. Kelly
-----------------------
Patrick C. Kelly
Chairman and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.
Signatures Title Date
- ------------------------ ------------------------------------- -------------
/s/ Patrick C. Kelly Chairman of the Board of Directors, July 16, 1999
- ------------------------ Chief Executive Officer, and Director
Patrick C. Kelly (Principal Executive Officer)
/s/ David A. Smith Executive Vice President, Chief July 16, 1999
- ------------------------ Financial Director (Principal
David A. Smith Financial and Accounting Officer)
Director
- ------------------------
Thomas G. Hixon
/s/ Hugh M. Brown Director July 16, 1999
- ------------------------
Hugh M. Brown
Director
- ------------------------
T. O'Neal Douglas
/s/ Melvin L. Heckman Director July 16, 1999
- ------------------------
Melvin L. Heckman
Director
- ------------------------
Delores Kesler
/s/ Charles R. Scott Director July 16, 1999
- ------------------------
Charles R. Scott
/s/ James L. L. Tullis Director July 16, 1999
- ------------------------
James L. L. Tullis
/s/ Donna Williamson Director July 16, 1999
- ------------------------
Donna Williamson
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized on October 28, 1999.
PSS WORLD MEDICAL, INC.
By: /s/ David A. Smith
----------------------------
David A. Smith
Executive Vice President and
Chief Financial Officer
